Florida ASCENT Study Evaluates Patient Navigator for Cancer Care Improvement
The Florida ASCENT Study aims to evaluate the MyCarePulse and ASCENT patient navigator intervention for cancer patients, focusing on food security and dietary behaviors.
Phase III
cancer care institutions
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The Florida ASCENT Study is poised to redefine cancer care by integrating nutritional support into treatment protocols, addressing critical social determinants of health. Its outcomes could set new standards for patient care, making it essential for pharma strategy teams to monitor developments closely.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from the ASCENT Questionnaire and overall patient outcomes related to food security and diet quality.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.